title: Cavernositis following intracavernous injection of vasoactive drugs.
abstract: Intracavernous injection is one of the most common treatments of erectile dysfunction. Infectious complications are rare, but hazardous. We report the case of a 44-year-old to stress the importance of patient supervision and drug prescription.
authors.affiliation: Department of Andrology, Fundación Puigvert, Barcelona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Vives
authors.forename: A
authors.initials: A
authors.lastname: Collado
authors.forename: N
authors.initials: N
authors.lastname: Ribé
authors.forename: J
authors.initials: J
authors.lastname: Segarra
authors.forename: E
authors.initials: E
authors.lastname: Ruiz Castañé
authors.forename: J M
authors.initials: JM
authors.lastname: Pomerol
mesh_terms: D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage* / Q000009:adverse effects; D001446:Balanitis / Q000139:chemically induced*; D006801:Humans; D007267:Injections; D008297:Male; D010413:Penis; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D000527:Alprostadil